Compare CVS Health Corp (CVS) vs Enphase Energy Inc (ENPH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Enphase Energy Inc — how do they compare? CVS Health Corp trades at $104.86 (market cap $135.48B), while Enphase Energy Inc trades at $45.05 (market cap $5.93B). The key difference: CVS Health Corp is far larger — about 22.8× Enphase Energy Inc's market cap, and CVS Health Corp pays a 2.51% dividend while Enphase Energy Inc pays none. Which is the better fit depends on your goals.
| CVS | ENPH | |
|---|---|---|
Market Cap | $135.48B | $5.93B |
Sector | Health | Technology |
52-Week High | $106.18 | $72.33 |
52-Week Low | $58.75 | $26.12 |
Enterprise Value | $202.02B | $5.58B |
Dividend Yield | 2.51% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
Enphase Energy (ENPH) trades at $43.06, down 3.95% on the day, near its consensus price target of $42.79. The stock shows a bearish technical signal with declining cash flows and mixed earnings trends, though recent quarters have beaten estimates. Recent news includes product expansions in Australia and New Zealand and involvement in AI data center power standards, providing some positive catalysts amid overall market caution.
Outlook remains cautious with high valuation ratios (P/E 44.39) pressuring upside, while analyst sentiment is divided (40% Buy, 51% Hold). Key risks include competitive pressures and volatile solar demand, but institutional interest and strategic initiatives offer potential for recovery if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Enphase Energy Inc
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →
